GLP-1 관련 제품 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 유통 채널별, 지역별 및 부문별 예측(2026-2033년)

GLP-1 Companion Products Market Summary

The global GLP-1 companion products market size was valued at USD 204.8 billion in 2025 and is projected to grow from USD 225.9 billion in 2026 to USD 479.0 billion by 2033, at a CAGR of 11.3% from 2026 to 2033. North America held the largest market share of 37.8% in 2025. Consumers using GLP-1 medications are increasingly seeking products that help address reduced appetite, support adequate protein intake, maintain hydration, promote digestive health, and preserve lean muscle mass during treatment.

This trend is encouraging manufacturers to develop specialized product portfolios, including high-protein foods and beverages, hydration solutions, digestive-health products, meal replacements, and nutrient-dense supplements tailored to the unique needs of GLP-1 users. The growing emphasis on personalized nutrition, preventive healthcare, and long-term weight-management support is accelerating market expansion. The increasing integration of digital health platforms, nutrition coaching, and AI-enabled wellness programs is further enhancing consumer engagement and treatment adherence, while ongoing product innovation and the entry of food, nutrition, and wellness companies into the GLP-1 ecosystem continue to create new growth opportunities for the GLP-1 companion product industry.

The market is growing as rising awareness of the nutritional and lifestyle challenges associated with GLP-1 therapy encourages consumers to adopt specialized support products into their daily health routines. Reduced appetite, lower food intake, digestive discomfort, hydration concerns, and the risk of lean muscle loss are prompting consumers to seek protein-enriched foods and beverages, hydration solutions, digestive health products, and micronutrient supplements to support overall well-being during treatment. In addition, the growing emphasis on preventive healthcare, healthy aging, and long-term weight management is accelerating demand for companion products that can help individuals maintain nutritional adequacy and sustain treatment outcomes.

Global GLP-1 Companion Products Market Report Segmentation

This report forecasts revenue growth at the global, regional & country level and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global GLP-1 companion product market report based on product, distribution channel, and region:

• Product Outlook (Revenue, USD Billion, 2021 - 2033)
• Muscle Preservation Powders
  • Protein Powders
  • RTD Protein Beverages
  • Protein Bars
  • Others
• Digestive Health Products
  • Fiber Supplements
  • Probiotics Supplements
  • Digestive Enzyme Supplements
  • Others
• Nutrient Density Support
  • Multivitamin Supplements
  • Meal Replacement Products
  • Others
• Appetite & Metabolic Support
  • Satiety Support Products
  • Appetite Management Supplements
  • Others
• Hydration & Recovery Products
  • Electrolyte Beverages
  • Recovery Hydration Products
  • Functional Hydration Mixes
  • Others
• Others
• Distribution Channel Outlook (Revenue, USD Billion, 2021 - 2033)
• Hypermarkets & Supermarkets
• Pharmacies & Drug Stores
• Specialty Stores
• D2C
• Online (E-commerce)
• MLM (Direct Sales)
• Others
• Regional Outlook (Revenue, USD Billion, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
• Asia Pacific
  • China
  • Japan
  • India
  • Australia & New Zealand
  • South Korea
  • Indonesia
  • Malaysia
  • Vietnam
  • Taiwan
• Central & South America
  • Brazil
  • Colombia
  • Ecuador
  • El Salvador
  • Peru
  • Honduras
• Middle East & Africa
  • Saudi Arabia
  • Turkey
• Eurasia
  • Mongolia
  • Kazakhstan
  • Uzbekistan

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources & Third-Party Perspectives
  • 1.3.4. Primary Research
• 1.4. Information Analysis
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Data Visualization
• 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Product Outlook
• 2.3. Distribution Channel Outlook
• 2.4. Competitive Landscape Outlook

Chapter 3. GLP-1 Companion Product Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. GLP-1 Companion Product Market Size & Growth Rate Overview, 2021 - 2033 (USD Billion)
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Industry Value Chain Analysis
  • 3.3.1. Raw Material Trends Outlooks
  • 3.3.2. Manufacturing and Technology Trends
  • 3.3.3. Profit Margin Analysis
• 3.4. Market Dynamics
  • 3.4.1. Market Driver Analysis
  • 3.4.2. Market Restraint Analysis
  • 3.4.3. Market Opportunities
  • 3.4.4. Market Challenges
• 3.5. Industry Analysis - Porter's Five Forces Analysis
• 3.6. Market Entry Strategies

Chapter 4. GLP-1 Companion Product Market: Consumer Behavior Analysis

• 4.1. Demographic Analysis
• 4.2. Consumer Trends & Preferences
• 4.3. Factors Influencing Buying Behavior
• 4.4. Consumer Service Adoption Trends
• 4.5. Key Observations & Findings

Chapter 5. GLP-1 Companion Product Market: Product Estimates & Trend Analysis

• 5.1. GLP-1 Companion Product Market, by Product: Key Takeaways
• 5.2. Product Movement Analysis & Market Share, 2025 & 2033
• 5.3. Market Estimates & Forecasts, by Product, 2021 - 2033 (USD Billion)
  • 5.3.1. Muscle Preservation Powders
    • 5.3.1.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 5.3.1.2. Protein Powders
      • 5.3.1.2.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 5.3.1.3. RTD Protein Beverages
      • 5.3.1.3.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 5.3.1.4. Protein Bars
      • 5.3.1.4.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 5.3.1.5. Others
      • 5.3.1.5.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 5.3.2. Digestive Health Products
    • 5.3.2.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 5.3.2.2. Fiber Supplements
      • 5.3.2.2.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 5.3.2.3. Probiotics Supplements
      • 5.3.2.3.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 5.3.2.4. Digestive Enzyme Supplements
      • 5.3.2.4.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 5.3.2.5. Others
      • 5.3.2.5.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 5.3.3. Nutrient Density Support
    • 5.3.3.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 5.3.3.2. Multivitamin Supplements
      • 5.3.3.2.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 5.3.3.3. Meal Replacement Products
      • 5.3.3.3.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 5.3.3.4. Others
      • 5.3.3.4.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 5.3.4. Appetite & Metabolic Support
    • 5.3.4.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 5.3.4.2. Satiety Support Products
      • 5.3.4.2.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 5.3.4.3. Appetite Management Supplements
      • 5.3.4.3.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 5.3.4.4. Others
      • 5.3.4.4.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 5.3.5. Hydration & Recovery Products
    • 5.3.5.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 5.3.5.2. Electrolyte Beverages
      • 5.3.5.2.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 5.3.5.3. Recovery Hydration Products
      • 5.3.5.3.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 5.3.5.4. Functional Hydration Mixes
      • 5.3.5.4.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 5.3.5.5. Others
      • 5.3.5.5.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 5.3.6. Others
    • 5.3.6.1. Market estimates and forecast, 2021 - 2033 (USD Billion)

Chapter 6. GLP-1 Companion Product Market: Distribution Channel Estimates & Trend Analysis

• 6.1. GLP-1 Companion Product Market, by Distribution Channel: Key Takeaways
• 6.2. Distribution Channel Movement Analysis & Market Share, 2025 & 2033
• 6.3. Market Estimates & Forecasts, by Distribution Channel, 2021 - 2033 (USD Billion)
  • 6.3.1. Hypermarkets & Supermarkets
    • 6.3.1.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 6.3.2. Pharmacies & Drug Stores
    • 6.3.2.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 6.3.3. Specialty Stores
    • 6.3.3.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 6.3.4. D2C
    • 6.3.4.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 6.3.5. Online (E-commerce)
    • 6.3.5.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 6.3.6. MLM (Direct Sales)
    • 6.3.6.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 6.3.7. Others
    • 6.3.7.1. Market estimates and forecast, 2021 - 2033 (USD Billion)

Chapter 7. GLP-1 Companion Product Market: Regional Estimates & Trend Analysis

• 7.1. GLP-1 Companion Product Market: Regional Outlook
• 7.2. Regional Movement Analysis & Market Share, 2025 & 2033
• 7.3. Market Estimates & Forecasts, by Region & Country, 2021 - 2033 (USD Billion)
  • 7.3.1. North America
    • 7.3.1.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 7.3.1.2. U.S.
      • 7.3.1.2.1. Key country dynamics
      • 7.3.1.2.2. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 7.3.1.3. Canada
      • 7.3.1.3.1. Key country dynamics
      • 7.3.1.3.2. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 7.3.1.4. Mexico
      • 7.3.1.4.1. Key country dynamics
      • 7.3.1.4.2. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 7.3.2. Europe
    • 7.3.2.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 7.3.2.2. Germany
      • 7.3.2.2.1. Key country dynamics
      • 7.3.2.2.2. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 7.3.2.3. UK
      • 7.3.2.3.1. Key country dynamics
      • 7.3.2.3.2. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 7.3.2.4. France
      • 7.3.2.4.1. Key country dynamics
      • 7.3.2.4.2. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 7.3.2.5. Italy
      • 7.3.2.5.1. Key country dynamics
      • 7.3.2.5.2. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 7.3.3. Asia Pacific
    • 7.3.3.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 7.3.3.2. China
      • 7.3.3.2.1. Key country dynamics
      • 7.3.3.2.2. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 7.3.3.3. Japan
      • 7.3.3.3.1. Key country dynamics
      • 7.3.3.3.2. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 7.3.3.4. India
      • 7.3.3.4.1. Key country dynamics
      • 7.3.3.4.2. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 7.3.3.5. Australia & New Zealand
      • 7.3.3.5.1. Key country dynamics
      • 7.3.3.5.2. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 7.3.3.6. South Korea
      • 7.3.3.6.1. Key country dynamics
      • 7.3.3.6.2. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 7.3.3.7. Indonesia
      • 7.3.3.7.1. Key country dynamics
      • 7.3.3.7.2. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 7.3.3.8. Malaysia
      • 7.3.3.8.1. Key country dynamics
      • 7.3.3.8.2. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 7.3.3.9. Vietnam
      • 7.3.3.9.1. Key country dynamics
      • 7.3.3.9.2. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 7.3.3.10. Taiwan
      • 7.3.3.10.1. Key country dynamics
      • 7.3.3.10.2. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 7.3.4. Central & South America
    • 7.3.4.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 7.3.4.2. Brazil
      • 7.3.4.2.1. Key country dynamics
      • 7.3.4.2.2. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 7.3.4.3. Colombia
      • 7.3.4.3.1. Key country dynamics
      • 7.3.4.3.2. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 7.3.4.4. Ecuador
      • 7.3.4.4.1. Key country dynamics
      • 7.3.4.4.2. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 7.3.4.5. El Salvador
      • 7.3.4.5.1. Key country dynamics
      • 7.3.4.5.2. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 7.3.4.6. Peru
      • 7.3.4.6.1. Key country dynamics
      • 7.3.4.6.2. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 7.3.4.7. Honduras
      • 7.3.4.7.1. Key country dynamics
      • 7.3.4.7.2. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 7.3.5. Middle East & Africa
    • 7.3.5.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 7.3.5.2. Saudi Arabia
      • 7.3.5.2.1. Key country dynamics
      • 7.3.5.2.2. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 7.3.5.3. Turkey
      • 7.3.5.3.1. Key country dynamics
      • 7.3.5.3.2. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 7.3.6. Eurasia
    • 7.3.6.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 7.3.6.2. Mongolia
      • 7.3.6.2.1. Key country dynamics
      • 7.3.6.2.2. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 7.3.6.3. Kazakhstan
      • 7.3.6.3.1. Key country dynamics
      • 7.3.6.3.2. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 7.3.6.4. Uzbekistan
      • 7.3.6.4.1. Key country dynamics
      • 7.3.6.4.2. Market estimates and forecast, 2021 - 2033 (USD Billion)

Chapter 8. Competitive Analysis

• 8.1. Recent Developments & Impact Analysis by Key Market Participants
• 8.2. Company Categorization
• 8.3. Participant's Overview
• 8.4. Financial Performance
• 8.5. Product Portfolios
• 8.6. Company Market Share Analysis, 2025 (%)
• 8.7. Company Heat Map Analysis
• 8.8. Strategy Mapping
• 8.9. Company Profiles
  • 8.9.1. Nature Made
    • 8.9.1.1. Company Overview
    • 8.9.1.2. Financial Performance
    • 8.9.1.3. Product Portfolios
    • 8.9.1.4. Strategic Initiatives
  • 8.9.2. Nestle S.A.
    • 8.9.2.1. Company Overview
    • 8.9.2.2. Financial Performance
    • 8.9.2.3. Product Portfolios
    • 8.9.2.4. Strategic Initiatives
  • 8.9.3. HerbaLife Ltd.
    • 8.9.3.1. Company Overview
    • 8.9.3.2. Financial Performance
    • 8.9.3.3. Product Portfolios
    • 8.9.3.4. Strategic Initiatives
  • 8.9.4. The Vitamin Shoppe
    • 8.9.4.1. Company Overview
    • 8.9.4.2. Financial Performance
    • 8.9.4.3. Product Portfolios
    • 8.9.4.4. Strategic Initiatives
  • 8.9.5. Conagra Brands Inc.
    • 8.9.5.1. Company Overview
    • 8.9.5.2. Financial Performance
    • 8.9.5.3. Product Portfolios
    • 8.9.5.4. Strategic Initiatives
  • 8.9.6. Danone S.A.
    • 8.9.6.1. Company Overview
    • 8.9.6.2. Financial Performance
    • 8.9.6.3. Type Portfolios
    • 8.9.6.4. Strategic Initiatives
  • 8.9.7. Abbott
    • 8.9.7.1. Company Overview
    • 8.9.7.2. Financial Performance
    • 8.9.7.3. Product Portfolios
    • 8.9.7.4. Strategic Initiatives
  • 8.9.8. Amway Corp
    • 8.9.8.1. Company Overview
    • 8.9.8.2. Financial Performance
    • 8.9.8.3. Product Portfolios
    • 8.9.8.4. Strategic Initiatives
  • 8.9.9. GNC
    • 8.9.9.1. Company Overview
    • 8.9.9.2. Financial Performance
    • 8.9.9.3. Product Portfolios
    • 8.9.9.4. Strategic Initiatives
  • 8.9.10. Smoothie King
    • 8.9.10.1. Company Overview
    • 8.9.10.2. Financial Performance
    • 8.9.10.3. Product Portfolios
    • 8.9.10.4. Strategic Initiatives